These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15882529)

  • 1. Multicomponent Lyme vaccine: three is not a crowd.
    Brown EL; Kim JH; Reisenbichler ES; Höök M
    Vaccine; 2005 May; 23(28):3687-96. PubMed ID: 15882529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease.
    Hassan WS; Giaretta PR; Rech R; Ollivault-Shiflett M; Esteve-Gasent MD
    Vaccine; 2019 Sep; 37(37):5596-5606. PubMed ID: 31387750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
    Izac JR; Oliver LD; Earnhart CG; Marconi RT
    Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
    Scheckelhoff MR; Telford SR; Hu LT
    Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.
    O'Connor TP; Esty KJ; Hanscom JL; Shields P; Philipp MT
    Clin Diagn Lab Immunol; 2004 May; 11(3):458-62. PubMed ID: 15138170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.
    Brandt KS; Patton TG; Allard AS; Caimano MJ; Radolf JD; Gilmore RD
    Clin Vaccine Immunol; 2014 Apr; 21(4):526-33. PubMed ID: 24501342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.
    Camire AC; Hatke AL; King VL; Millership J; Ritter DM; Sobell N; Weber A; Marconi RT
    Vet J; 2021 Jul; 273():105676. PubMed ID: 34148599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Serodiagnostic Performance for Lyme Disease by Use of Two Recombinant Proteins in Enzyme-Linked Immunosorbent Assay Compared to Standardized Two-Tier Testing.
    Bradshaw GL; Thueson RK; Uriona TJ
    J Clin Microbiol; 2017 Oct; 55(10):3046-3056. PubMed ID: 28768731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.
    Edmondson DG; Prabhakaran S; Norris SJ; Ullmann AJ; Piesman J; Dolan M; Probst C; Radzimski C; Stöcker W; Komorowski L
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27733423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An octavalent lyme disease vaccine induces antibodies that recognize all incorporated OspC type-specific sequences.
    Earnhart CG; Marconi RT
    Hum Vaccin; 2007; 3(6):281-9. PubMed ID: 17921702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses.
    Guarino C; Asbie S; Rohde J; Glaser A; Wagner B
    Vaccine; 2017 Jul; 35(33):4140-4147. PubMed ID: 28668566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design of a second-generation Lyme disease vaccine based on a C-terminal fragment of Borrelia burgdorferi OspA.
    Koide S; Yang X; Huang X; Dunn JJ; Luft BJ
    J Mol Biol; 2005 Jul; 350(2):290-9. PubMed ID: 15935380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status.
    Gomes-Solecki MJ; Wormser GP; Schriefer M; Neuman G; Hannafey L; Glass JD; Dattwyler RJ
    J Clin Microbiol; 2002 Jan; 40(1):193-7. PubMed ID: 11773115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of OspC chimeritope vaccinogens for Lyme disease.
    Izac JR; O'Bier NS; Oliver LD; Camire AC; Earnhart CG; LeBlanc Rhodes DV; Young BF; Parnham SR; Davies C; Marconi RT
    Vaccine; 2020 Feb; 38(8):1915-1924. PubMed ID: 31959423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP.
    Křupka M; Mašek J; Bartheldyová E; Turánek Knötigová P; Plocková J; Korvasová Z; Škrabalová M; Koudelka Š; Kulich P; Zachová K; Czerneková L; Strouhal O; Horynová M; Šebela M; Miller AD; Ledvina M; Raška M; Turánek J
    J Control Release; 2012 Jun; 160(2):374-81. PubMed ID: 22387453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
    Goettner G; Schulte-Spechtel U; Hillermann R; Liegl G; Wilske B; Fingerle V
    J Clin Microbiol; 2005 Aug; 43(8):3602-9. PubMed ID: 16081885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Borrelia burgdorferi BbHtrA Protease as a Vaccine Candidate for Lyme Borreliosis in Mice.
    Ullmann AJ; Russell TM; Dolan MC; Williams M; Hojgaard A; Weiner ZP; Johnson BJ
    PLoS One; 2015; 10(6):e0128868. PubMed ID: 26076465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination.
    Molloy PJ; Berardi VP; Persing DH; Sigal LH
    Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.